Phreesia, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Phreesia, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $419.81M | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | $356.30M | Mar 13, 2025 |
| FY2025 | Jan 31, 2023 | $280.91M | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | $213.23M | Mar 15, 2024 |
| FY2023 | Jan 31, 2021 | $148.68M | Mar 23, 2023 |
| FY2020 | Jan 31, 2020 | $32.82M | Apr 23, 2020 |
| FY2020 | Oct 31, 2019 | $32.84M | Apr 23, 2020 |
| FY2020 | Jul 31, 2019 | $30.82M | Apr 23, 2020 |
| FY2020 | Apr 30, 2019 | $28.31M | Apr 23, 2020 |
| FY2020 | Jan 31, 2019 | $26.48M | Apr 23, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | ($58.53M) | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | ($136.89M) | Mar 13, 2025 |
| FY2025 | Jan 31, 2023 | ($176.15M) | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | ($118.16M) | Mar 15, 2024 |
| FY2023 | Jan 31, 2021 | ($27.29M) | Mar 23, 2023 |
| FY2020 | Jan 31, 2020 | ($3.67M) | Apr 23, 2020 |
| FY2020 | Oct 31, 2019 | ($2.44M) | Apr 23, 2020 |
| FY2020 | Jul 31, 2019 | ($7.49M) | Apr 23, 2020 |
| FY2020 | Apr 30, 2019 | ($6.70M) | Apr 23, 2020 |
| FY2020 | Jan 31, 2019 | ($5.08M) | Apr 23, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | ($58.10M) | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | ($136.48M) | Mar 13, 2025 |
| FY2025 | Jan 31, 2023 | ($176.55M) | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | ($116.82M) | Mar 15, 2024 |
| FY2023 | Jan 31, 2021 | ($25.67M) | Mar 23, 2023 |
| FY2020 | Jan 31, 2020 | ($4.67M) | Apr 23, 2020 |
| FY2020 | Oct 31, 2019 | ($2.23M) | Apr 23, 2020 |
| FY2020 | Jul 31, 2019 | ($4.14M) | Apr 23, 2020 |
| FY2020 | Apr 30, 2019 | ($4.26M) | Apr 23, 2020 |
| FY2020 | Jan 31, 2019 | ($3.30M) | Apr 23, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $388.42M | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | $370.33M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | $370.06M | Mar 15, 2024 |
| FY2023 | Jan 31, 2022 | $494.48M | Mar 23, 2023 |
| FY2022 | Jan 31, 2021 | $326.67M | Mar 31, 2022 |
| FY2021 | Jan 31, 2020 | $158.76M | Mar 31, 2021 |
| FY2020 | Jan 31, 2019 | $59.26M | Apr 23, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $123.61M | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | $118.88M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | $82.24M | Mar 15, 2024 |
| FY2023 | Jan 31, 2022 | $77.20M | Mar 23, 2023 |
| FY2022 | Jan 31, 2021 | $63.36M | Mar 31, 2022 |
| FY2021 | Jan 31, 2020 | $56.89M | Mar 31, 2021 |
| FY2020 | Jan 31, 2019 | $63.75M | Apr 23, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $264.81M | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | $251.45M | Mar 13, 2025 |
| FY2025 | Jan 31, 2023 | $287.82M | Mar 13, 2025 |
| FY2025 | Jan 31, 2022 | $417.28M | Mar 13, 2025 |
| FY2024 | Jan 31, 2021 | $263.31M | Mar 15, 2024 |
| FY2023 | Jan 31, 2020 | $101.87M | Mar 23, 2023 |
| FY2022 | Jan 31, 2019 | ($210.97M) | Mar 31, 2022 |
| FY2021 | Jan 31, 2018 | ($167.68M) | Mar 31, 2021 |
| FY2020 | Jan 31, 2017 | ($130.46M) | Apr 23, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | (1) | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | (2) | Mar 13, 2025 |
| FY2025 | Jan 31, 2023 | (3) | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | (2) | Mar 15, 2024 |
| FY2023 | Jan 31, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Jan 31, 2020 | (4) | Mar 31, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | (1) | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | (2) | Mar 13, 2025 |
| FY2025 | Jan 31, 2023 | (3) | Mar 13, 2025 |
| FY2024 | Jan 31, 2022 | (2) | Mar 15, 2024 |
| FY2023 | Jan 31, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Jan 31, 2020 | (4) | Mar 31, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $84.22M | Mar 13, 2025 |
| FY2025 | Jan 31, 2024 | $87.52M | Mar 13, 2025 |
| FY2024 | Jan 31, 2023 | $176.68M | Mar 15, 2024 |
| FY2023 | Jan 31, 2022 | $313.81M | Mar 23, 2023 |
| FY2022 | Jan 31, 2021 | $218.78M | Mar 31, 2022 |
| FY2021 | Jan 31, 2020 | $90.32M | Mar 31, 2021 |
| FY2020 | Jan 31, 2019 | $1.54M | Apr 23, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $1.94M | Mar 13, 2025 |
| FY2024 | Jan 31, 2024 | $3.15M | Mar 15, 2024 |
| FY2023 | Jan 31, 2023 | $246.0K | Mar 23, 2023 |
| FY2022 | Jan 31, 2022 | $360.0K | Mar 31, 2022 |
| FY2021 | Jan 31, 2021 | $1.63M | Mar 31, 2021 |